Form 4: Trulieve Director Susan Thronson Acquires Stock Options
SEC Form 4 Filing
Director Susan Thronson reports acquisition of stock options in Trulieve Cannabis Corp.
Summary
- On March 25, 2025, Susan Thronson, a director of Trulieve Cannabis Corp., acquired 32,430 stock options with an exercise price of $4.03.
- The options are fully vested and expire on March 25, 2032.
- Following the transaction, Thronson directly owns 32,430 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It simply reports the acquisition of stock options by a company director.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders, allowing investors to monitor their investment.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date of earliest transaction: Acquisition of stock options. |
| 03/25/2025 | Date exercisable for stock options. |
| 03/25/2032 | Expiration date for stock options. |
| 03/28/2025 | Date of signature for the Form 4 filing. |
Keywords
stock options, Form 4, director, Trulieve, acquisition, beneficial ownership, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.